Szelachowska M - Search Results

1

[The C-peptide as a risk factor of development of type 1 diabetes in the first degree relatives of the autoimmunological diabetic patients].

Siewko K, Szelachowska M, Popławska-Kita A, Szpak P, Nikołajuk A, Górska M. Siewko K, et al. Among authors: szelachowska m. Endokrynol Pol. 2009 Sep-Oct;60(5):357-62. Endokrynol Pol. 2009. PMID: 19885806 Polish.

2

[Activity of Ca(+2)Mg(+2) --ATPase in erythrocyte membranes of women with diabetes mellitus type I].

Szelachowska M, Schaefer W, Gries AF, Kinalska I. Szelachowska M, et al. Endokrynol Pol. 1992;43(1):23-9. Endokrynol Pol. 1992. PMID: 1345522 Polish.

3

Iodine deficiency disorders in the north-eastern region of Poland (Białystok coordinating center).

Kinalska I, Borawski J, Kretowski A, Szelachowska M, Popławska A, Wysocka B. Kinalska I, et al. Among authors: szelachowska m. Endokrynol Pol. 1993;44(3):297-304. Endokrynol Pol. 1993. PMID: 8055798

4

Orally given nicotinamide inhibits the decreasing of glutathione content in the pancreas of streptozotocin diabetic rats.

Kretowski A, Szelachowska M, Górska M, Zendzian-Piotrowska M, Wysocka-Sołowie B, Kinalska I. Kretowski A, et al. Among authors: szelachowska m. Horm Metab Res. 1996 Jan;28(1):35-6. doi: 10.1055/s-2007-979127. Horm Metab Res. 1996. PMID: 8820993 No abstract available.

5

[Diabetic foot--an attempt at defining the risk factors for amputation].

Myśliwiec J, Zarzycki W, Górska M, Pedich M, Szelachowska M, Kinalska I. Myśliwiec J, et al. Among authors: szelachowska m. Pol Arch Med Wewn. 1997 Jul;98(7):33-8. Pol Arch Med Wewn. 1997. PMID: 9499207 Clinical Trial. Polish.

6

Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I.

Szelachowska M, Kretowski A, Kinalska I. Szelachowska M, et al. Horm Metab Res. 1998 Aug;30(8):526-30. doi: 10.1055/s-2007-978926. Horm Metab Res. 1998. PMID: 9761385

7

In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.

Kretowski A, Myśliwiec J, Szelachowska M, Brzozowski C, Pietruczuk M, Kinalska I. Kretowski A, et al. Among authors: szelachowska m. Arch Immunol Ther Exp (Warsz). 1999;47(1):45-9. Arch Immunol Ther Exp (Warsz). 1999. PMID: 11729828

8

Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.

Myśliwiec J, Kretowski A, Topolska J, Siewko K, Jakubczyk D, Szelachowska M, Mikita A, Kinalska I. Myśliwiec J, et al. Among authors: szelachowska m. Horm Metab Res. 2001 Dec;33(12):739-43. doi: 10.1055/s-2001-19135. Horm Metab Res. 2001. PMID: 11753760

9

[Clinical, biochemical and immunological characteristic of diabetes type I, LADA, diabetes type II, and MODY patients].

Szepietowska B, Szelachowska M, Górska M, Stepień A, Kinalska I. Szepietowska B, et al. Among authors: szelachowska m. Pol Arch Med Wewn. 2002 Dec;108(6):1177-84. Pol Arch Med Wewn. 2002. PMID: 12687930 Polish.

10

[Clinical and immunological profile of newly diagnosed non-obese adult patients with diabetes].

Szelachowska M, Szepietowska B, Popławska A, Jakubczyk D, Górska M, Kinalska I. Szelachowska M, et al. Przegl Lek. 2002;59(11):885-7. Przegl Lek. 2002. PMID: 12715714 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters